Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Benign Hematology
•
Thalassemia
What could explain failure to luspatercept in patients with transfusion-dependent beta thalassemia?
Related Questions
Is there specific data on using luspatercept for sickle beta+ thalassemia with transfusion-dependent anemia?
How would you approach hormone replacement therapy for perimenopause in a patient with increased risk factors for VTE (hereditary thrombophilia without personal thrombosis, family history of thrombophilia or thrombosis, etc.)?
How often do you check weight and adjust anticoagulation dosing in pregnancy?
How would you manage elevated vWF and FVIII levels in a patient with a family history of coagulopathy?
In a patient with type I von Willebrand disease who is pregnant and at increased risk for preeclampsia, would you recommend treatment with aspirin?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
How would you manage ITP in patients who develop cirrhosis and hemorrhage?
Would you consider long term avatrombopag use in patients with cirrhosis requiring higher platelet counts for medical therapy?
How do you manage copper deficiency?
How would you manage symptomatic superficial vein thrombosis during pregnancy?
